BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26430364)

  • 1. Expression of E-cadherin in normal oral mucosa, in oral precancerous lesions and in oral carcinomas.
    Sridevi U; Jain A; Nagalaxmi V; Kumar UV; Goyal S
    Eur J Dent; 2015; 9(3):364-372. PubMed ID: 26430364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin Expression in Premalignant Lesions, Premalignant Conditions, Oral Squamous Cell Carcinoma, and Normal Mucosa: An Immunohistochemical Study.
    Kalaimani G; Rao UDK; Joshua E; Ranganathan K
    Cureus; 2023 Aug; 15(8):e44266. PubMed ID: 37772225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Evaluation of Mitochondrial Antioxidants in Oral Potentially Malignant Disorders.
    Banerjee S; Mukherjee S; Mitra S; Singhal P
    Kurume Med J; 2020 Jul; 66(1):15-27. PubMed ID: 32378537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Survivin in Oral Potentially Malignant Disorders: An Immunohistochemical Study.
    Rajanna VR; Raveendranath MC; Kathiresan S; Srinivasan S; Ilango J
    J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S382-S388. PubMed ID: 33149491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of Bcl-2 and Ki-67 in oral lichen planus and leukoplakia with different degrees of dysplasia.
    Pigatti FM; Taveira LA; Soares CT
    Int J Dermatol; 2015 Feb; 54(2):150-5. PubMed ID: 25265990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
    Gupta K; Metgud R; Gupta J
    J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative Immunoexpression of EGFR in Oral Potentially Malignant Disorders: Oral Leukoplakia and Oral Submucous Fibrosis.
    Jyothi Meka N; Ugrappa S; Velpula N; Kumar S; Naik Maloth K; Kodangal S; Ch L; Goyal S
    J Dent Res Dent Clin Dent Prospects; 2015; 9(3):166-74. PubMed ID: 26697149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry.
    Srinivasan M; Jewell SD
    Oncology; 2001; 61(4):284-92. PubMed ID: 11721175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Collagen in Leukoplakia, Oral Submucous Fibrosis and Oral Squamous Cell Carcinomas Using Polarizing Microscopy and Immunohistochemistry.
    Arora KS; Nayyar A; Kaur P; Arora KS; Goel A; Singh S
    Asian Pac J Cancer Prev; 2018 Apr; 19(4):1075-1080. PubMed ID: 29699065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of Cytokeratin 17 during Oral Carcinogenesis: An Immunohistochemical Study.
    Sanguansin S; Kosanwat T; Juengsomjit R; Poomsawat S
    Int J Dent; 2021; 2021():4089549. PubMed ID: 34853592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2, MMP-7 expression in oral lichen planus and oral squamous cell carcinoma.
    Li TJ; Cui J
    Asian Pac J Trop Med; 2013 Aug; 6(8):640-3. PubMed ID: 23790336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
    Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
    Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
    Jaafari-Ashkavandi Z; Aslani E
    Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma.
    Hung KF; Chang CS; Liu CJ; Lui MT; Cheng CY; Kao SY
    J Oral Pathol Med; 2006 Nov; 35(10):589-94. PubMed ID: 17032390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunohistochemical expression of epithelial- mesenchymal transition markers E-cadherin, Twist and Snail in oral submucous fibrosis and their possible association with malignant transformation.
    Hosur MB; Puranik RS; Vanaki SS; Puranik SR; Sudhakara M; Das S
    J Oral Maxillofac Pathol; 2021; 25(1):97-104. PubMed ID: 34349418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.